OTCMKTS:BVNRY Bavarian Nordic Q2 2026 Earnings Results & Report $12.27 0.00 (0.00%) As of 11/9/2026 02:18 PM Eastern Bavarian Nordic reported Q2 2026 earnings on August 21, 2026. The company reported EPS of $0.46, while revenue was $316.47 million. Research:ProfileEarnings History Earnings Announcement Details QuarterQ2 2026Report DateAugust 21, 2026TimeBefore Market Opens Bavarian Nordic EPS ResultsActual EPS$0.46Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AEPS Beat Rate4 of last 5 quartersBavarian Nordic Revenue ResultsActual Revenue$316.47 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesEarnings HistoryCompany Profile Bavarian Nordic Q2 2026 Earnings FAQ Did Bavarian Nordic beat earnings estimates for Q2 2026? Bavarian Nordic (OTCMKTS:BVNRY) reported earnings of $0.46 per share for Q2 2026. The report was announced on Friday, August 21, 2026. What was Bavarian Nordic's revenue for Q2 2026? Bavarian Nordic reported revenue of $316.47 million for Q2 2026. Bavarian Nordic Earnings HeadlinesBavarian Nordic Awarded 4 Year Mpox And Smallpox Vaccine Supply Contract By UK GovernmentNovember 2, 2026 | rttnews.comBavarian Nordic gets four-year contract for mpox and smallpox vaccine from UK governmentNovember 2, 2026 | reuters.comToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th.November 10 at 1:00 AM | Behind the Markets (Ad)Bavarian Nordic to provide over 200K Mpox shots to global emergency stockpileOctober 27, 2026 | msn.comBavarian Nordic donates 75,000 mpox vaccine doses to global emergency stockpileOctober 27, 2026 | reuters.comBavarian Nordic Earnings Call Signals Profitable GrowthAugust 29, 2026 | tipranks.comSee More Bavarian Nordic Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Bavarian Nordic? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bavarian Nordic and other key companies, straight to your email. Email Address About Bavarian NordicBavarian Nordic (OTCMKTS:BVNRY) is a Danish biotechnology company that develops, manufactures and markets vaccines for infectious diseases and cancer immunotherapy. Founded in 1994, the company is based in Denmark and serves markets in Europe, North America and other regions. Its best-known vaccine is JYNNEOS, also marketed as IMVANEX in Europe and IMVAMUNE in Canada, for protection against smallpox and mpox. Bavarian Nordic also offers vaccines for diseases including rabies, tick-borne encephalitis, typhoid fever and cholera. The company uses its MVA-BN technology in vaccine development and supplies products to public health authorities as well as commercial markets. Its portfolio includes vaccines developed in-house and products added through acquisitions.View Bavarian Nordic ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Barrick's Earnings Beat Could Be Overshadowed by an Even Bigger OpportunityAxon vs. Motorola: Which Public Safety Stock Has More Upside After Q3 Earnings?Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?Wall Street May Be Making a Big Mistake With monday.com StockCloudflare's 20% Sell-Off May Have Created an Opening for InvestorsMarketBeat Week in Review – 11/2 - 11/6IonQ's Record Revenue Includes a Big SkyWater Boost: Does That Change the Story? Upcoming Earnings Brookfield (11/12/2026)NU (11/12/2026)Applied Materials (11/12/2026)Cisco Systems (11/12/2026)Mizuho Financial Group (11/13/2026)Mitsubishi UFJ Financial Group (11/13/2026)Sumitomo Mitsui Financial Group (11/13/2026)Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
